Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
HER2 弱陽性(HER2-low)乳癌新分類:trastuzumab deruxtecan 的擴展與後續挑戰
HER2 弱陽性(HER2-low)乳癌新分類:trastuzumab deruxtecan 的擴展與後續挑戰
Fuente:
Zenodo
Saved in:
Bibliographic Details
Main Author:
Lin, Hsieh-Ting
Format:
Recurso digital
Language:
Chinese
Published:
Zenodo
2026
Subjects:
乳癌
HER2-low
trastuzumab deruxtecan
T-DXd
DESTINY-Breast
衛教
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://doi.org/10.5281/zenodo.20115186
Similar Items
化療、標靶、免疫療法、放療差在哪?一張表看懂
by: Lin, Hsieh-Ting
Published: (2026)
Impacto del cambio de presentación del trastuzumab para la Seguridad Social de Costa Rica, estudio de minimización de costos
by: José Antonio Castro Cordero
Published: (2019)
The Takayuki Model: Foundational Education for a Resilient Future — Why Literacy Before 10 Can Change the World
by: 上田, 高之
Published: (2025)
La importancia de la determinación del HER2 en el cáncer gástrico avanzado: a propósito de un caso clínico
by: Ricardo Oliveros
Published: (2021)
Pertuzumab and trastuzumab: the rationale way to synergy
by: Sandrine Richard
Published: (2016)